A valid prescription requires a telehealth consultation with a licensed provider. No medication is dispensed without clinical evaluation.
Semaglutide
GLP-1 Receptor Agonist
Compound Specifications
Semaglutide
GLP-1 Receptor Agonist
Semaglutide is a well-studied GLP-1 receptor agonist evaluated in clinical trials for its effects on glycemic response, gastric emptying, and hypothalamic satiety signaling, and is prescribed under medical supervision for weight management.
Selectively activates GLP-1 receptors in the brain and gut, elevating postprandial insulin release while suppressing glucagon secretion. Slows gut motility to promote prolonged fullness.
Documented Therapeutic Benefits
Results may vary. Individual outcomes depend on adherence, baseline health, and other factors.
Administered via weekly subcutaneous injection, slowly titrated under clinical guidance from 0.25mg upwards to optimal tolerance.
Frequently Asked Clinical Questions
How is Semaglutide shipped?
Shipped directly to your doorstep in insulated, temperature-controlled cold packs with tracking.
Where is this medication compounded?
Compounded and shipped from licensed U.S. compounding pharmacies pursuant to a patient-specific prescription.
Can I take Semaglutide with peptides?
Yes, many patients pair Semaglutide with BPC-157 or NAD+ for muscle preservation and mitochondrial vitality.